recent articles

During the event, we will be showcasing our entire digital pathology portfolio. Here we are particularly proud to share our work in advancing PD-L1 testing based on the patented VirtualTripleStaining™ and its utility in automated assessment...

Join Visiopharm at USCAP 2017 and learn about how we are transforming pathology! Come see demonstrations of Analysis of PD-L1 and CD Markers within the Tumor Micro-Environment Visualize and quantify biomarker expression with heatmaps...

New applications on the platform enable acceleration of breakthroughs in the fight against cancer. Baltimore, MD; San Diego, CA (PRWEB) October 24, 2016 -- Proscia Inc, the industry's leading provider of cloud solutions for digital...

Three Events - One Product Family! Join Applied Spectral Imaging at the following events in March to learn about ASI’s GenASIs Platform. Accurate. Standardized. Immediate USCAP 2015 - United States & Canadian Academy of...

Join ASI in booth # 223 at CAP’14 – THE Pathologists’ Meeting Come see ASI’s GenASIs HiPath, the latest Pathology Quantitative Diagnostic Aid, providing solutions for any sized lab! Ask questions from our experts, see a demo and get...

Exciting news from Visiopharm - their Ki67 diagnostic App has received the CE mark for in-vitro diagnostic use in Europe. The Virtual Double Staining (VDS) Ki67 module for breast is a novel, patented and now CE-marked diagnostic APP intended...

OR

platinum partners

gold partners

Silver Partners

Media Partners